Clinical Trial Update: Neoadjuvant Immunotherapy Combined With Chemotherapy in Patients With Locally Advanced ESCC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neoadjuvant immunotherapy combined with chemotherapy for locally advanced esophageal squamous cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Esophagus Cancer | Phase 2 | Status: COMPLETED